Classical studies of receptor-mediated endocytosis established the principle of geometric sorting, whereby membrane-bound receptors recycle to the plasma membrane by bulk membrane flow and require specific membrane sorting machinery in order to traffic to lysosomes (1-3).
Introduction
Classical studies of receptor-mediated endocytosis established the principle of geometric sorting, whereby membrane-bound receptors recycle to the plasma membrane by bulk membrane flow and require specific membrane sorting machinery in order to traffic to lysosomes (1-3).
Although many signaling receptors are endocytosed after ligand-induced activation, there are large differences in the degree to which various receptors thereafter traffic to lysosomes. Such differences in the endocytic trafficking of receptors have important functional consequences (4) (5) (6) . In the case of G protein-coupled receptors (GPCRs), events surrounding the initial endocytosis of receptors generally result in a rapid desensitization of signaling activity.
Recycling of receptors back to the plasma membrane typically promotes functional resensitization, whereas sorting of internalized receptors to lysosomes leads to proteolytic downregulation of receptors and a prolonged attenuation of signal transduction (7) (8) (9) . These considerations have motivated considerable interest in elucidating mechanisms that control the sorting of specific signaling receptors in the endocytic pathway.
Covalent modification of lysine residues by ubiquitin is well known to function as a signal targeting many proteins to proteasomes. Ubiquitination of cytoplasmic lysine residues has emerged more recently as a mechanism that also regulates the endocytic trafficking of various integral membrane proteins (10) . Ubiquitination of lysine residues located in the carboxylterminal cytoplasmic domain of the yeast GPCR Ste2p was initially shown to promote ligandinduced endocytosis of receptors (11) . More recently, ubiquitination of the cytoplasmic tail of Ste2p (12) has been shown to be essential for the subsequent sorting of endocytosed receptors to internal structures of the vacuole via a mechanism involving ubiquitin-dependent protein interactions occurring on the endosomal membrane (12, 13) . Ubiquitination of receptor tyrosine kinases such as the EGF receptor plays an analogous role in sorting of internalized receptors to lysosomes in mammalian cells (14, 15) . Recent studies of the CXCR4 chemokine receptor and beta-2 adrenergic receptor provide strong evidence that ubiquitination of cytoplasmic lysine residues is also essential for lysosomal trafficking of certain mammalian GPCRs (16,17).
Opioid receptors comprise a subfamily of mammalian GPCRs that transduce the physiological effects of endogenously produced neuropeptides as well as exogenously administered alkaloid analgesic drugs. The delta opioid receptor (DOR) is regulated by ligand-induced endocytosis followed by post-endocytic trafficking to lysosomes in several cell types (18-21). Ubiquitination of opioid receptors in the biosynthetic pathway has been shown to target DOR to proteasomes from the endoplasmic reticulum (22) but the potential role of ubiquitination in mediating endocytic trafficking of DOR to lysosomes has not been investigated. There is accumulating evidence that the endocytic sorting of mammalian GPCRs can be modulated by a variety of noncovalent protein interactions (21,23-25), raising the question of whether ubiquitination is actually required for lysosomal trafficking of receptors in all cases. Furthermore, it has been argued that ligand-induced downregulation of DOR can occur under some conditions by a distinct, ubiquitindependent mechanism involving targeting of receptors to proteasomes from the plasma membrane, which is entirely distinct from downregulation mediated by receptor trafficking to lysosomes (26).
With these considerations in mind we have investigated the potential role of proteasome activity and covalent ubiquitination in mediating ligand-induced proteolysis of DOR in HEK293 cells, a 
Experimental Procedures cDNA Constructs
A FLAG-tagged version of the cloned murine DOR-1(27) was described previously (5). The DOR-0CK mutant DOR was generated using Quickchange site-directed mutagenesis (Stratagene) with pcDNA3-SFDOR as template. Codons encoding all eight cytoplasmic lysine residues were mutated to Arg using successive rounds of mutagenesis. Mutated cDNAs were cloned into pcDNA3 (Invitrogen), sequences were verified by dideoxynucleotide sequencing (University of California San Francisco Genetics Core Facility).
Cell culture and transfection
Human embryonic kidney (HEK) 293 cells (ATCC) were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (University of California San Francisco Cell Culture Facility). Cells grown in 6-cm culture dishes were transfected with 5 µg of plasmid DNA encoding the indicated receptor using calcium phosphate co-precipitation according to standard methods (28). For studies of receptor trafficking in transiently transfected cells, cells were transfected as above and plated onto glass cover slips 24 h after transfected and experiments were conducted 24 -48 h thereafter. Stably transfected cells expressing epitopetagged receptors were generated by selection for neomycin resistance using 500 µg/ml G418 (Geneticin, Life Technologies, Inc.). Colonies representing individual neo R clones were isolated, and clones were selected for further study based on receptor expression levels (assessed by fluorescence flow cytometry and western blot of cell lysates using M1 anti-FLAG antibody).
Radioligand binding assay using 3H-diprenorphine (Amersham) as tracer indicated that this expression level corresponds to 0.5 -1pmol receptor/mg membrane protein. 
Surface biotinylation and assays of receptor proteolysis
A previously described cell surface biotinylation method was used to specifically detect FLAGtagged receptors present in the plasma membrane and to measure their proteolysis (Tsao) .
Briefly, stably transfected 293 cells expressing the indicated FLAG-tagged receptors were grown in 10 cm dishes, washed twice with ice-cold PBS and incubated with 300 µg/ml sulfo-NHSbiotin (Pierce) in PBS for 30 min at 4 °C in order to biotinylate surface proteins. Unreacted biotin was quenched and removed with 3 washes of ice-cold TBS. Biotinylated cells were then transferred to pre-warmed media containing 10 µM of the appropriate agonist for the indicated times, then cells were immediately chilled on ice and lysed in extraction buffer (1.0% v/v Triton X100, 10 mM Tris-HCl, pH 7.5, 120 mM NaCl, 25 mM KCl, 1 µg/ml leupeptin, 1 µg/ml pepstatin, 2 µg/ml aprotinin, and 0.5 mM PMSF). Extracts were clarified by centrifugation (12,000 X g for 20 min), then biotinylated proteins were isolated from cell extracts by immobilization on streptavidin-conjugated Sepharose beads (Pharmacia) and washing 5 times in PBS containing 0.5% Triton X-100 to remove nonspecifically bound material. Washed beads were eluted with SDS sample buffer, and eluted proteins were resolved by SDS-PAGE, transferred to nitrocellulose membranes and probed for FLAG-tagged receptor by immunoblotting using M1 antibody, HRP-conjugated goat anti-mouse IgG (Amersham), and SuperSignal detection reagent (Pierce). Band intensities were quantified by densitometry of films exposed in the linear range using a range of lysates run in parallel as reference, imaged using a charge coupled device camera, and analyzed using 
Fluorescence microscopy
Endocytic trafficking of receptors initially labeled in the plasma membrane was visualized by fluorescence microscopy using a previously described "antibody feeding" method (23). Briefly, transiently transfected 293 cells were grown on glass cover slips (Corning) and surface receptors were specifically labeled by incubating intact cells with anti-FLAG antibody (2.0 µg/ml, Sigma).
Surface-labeled cells were subsequently incubated (37°C for 30 min) in the presence of the opioid peptide agonist (10 µM DADLE) for the indicated times and cells were then fixed using 4% formaldehyde in PBS and processed for immunocytochemical staining as described previously (5). Lysosomes were localized using LAMP1 monoclonal antibody obtained from the Developmental Studies Hybridoma Data Bank. Confocal fluorescence microscopy was performed using a Zeiss LSM510 microscope fitted with a Zeiss 63XNA1.4 objective, operated in single photon mode with standard filter sets and standard (1 Airy disc) pinhole. 
Results and Discussion
Based on a previous report that ligand-induced degradation of DOR is mediated primarily by proteasomes rather than lysosomes (26), we re-examined the effects of inhibitors of proteasome function on ligand-induced degradation of FLAG-tagged DOR expressed in stably transfected HEK293 cells, the same model system in which we have previously observed that ligandinduced degradation of receptors is highly sensitive to inhibitors of lysosomal proteolysis (5).
To our initial surprise, immunoblotting using anti-FLAG antibody indicated that the proteasome inhibitor MG132 strongly inhibited ligand-induced degradation of DOR (Fig 1 A) without detectably inhibiting ligand-induced internalization of receptors (Fig 1 B) , closely similar to results obtained previously using inhibitors of lysosomal function (5). Indeed, although MG132
is a highly potent inhibitor of a number of proteasome-associated proteases, this compound is not specific for proteasomes and also potently inhibits various cysteine proteases and cathepsins (29) , (30) . Thus we next examined the effects of lactacystin, a somewhat less potent but much more highly specific inhibitor of proteasome function (30) . Lactacystin, in contrast to MG132, did not detectably inhibit ligand-induced degradation of DOR (Fig 1C, upper panels) , even though we used this compound at a high concentration (40 µM) that is in significant excess of that shown previously to strongly inhibit proteasome activity (31) . Previous studies have receptors to lysosomes (15,31,33). Thus, in addition to validating the efficacy of lactacystin as a proteasome inhibitor under our experimental conditions, the inhibitory effect of this compound on EGF receptor but not DOR degradation suggested that DOR might be less dependent on ubiquitination than EGFR for its endocytic trafficking to lysosomes. The failure of lactacystin to inhibit ligand-induced proteolysis of DOR was confirmed in multiple experiments using densitometric scanning to quantify receptor degradation (Fig 1D) .
To test directly whether ubiquitination of DOR is required for its ligand-induced degradation, we constructed a mutant receptor in which all eight cytoplasmic lysine residues present in DOR were replaced by arginine (DOR-0cK mutant receptor, Fig. 2A ). This strategy prevents ubiquitination of receptors because protein ubiquitination occurs specifically on the ε-amino group of lysine (16,34). Lysine mutations of the CXCR4 chemokine receptor and beta-2 adrenergic receptor have been shown to block receptor ubiquitination and also to strongly inhibit receptor sorting to lysosomes (16,17). FLAG-tagged versions of DOR and DOR-0cK were expressed at similar moderate levels (0.5 -1 pmol/mg) in stably transfected HEK293 cells, expression levels at which DOR is efficiently sorted to lysosomes after ligand-induced endocytosis (5). Fluorescence flow cytometry (35) indicated that both DOR and DOR-0cK were internalized rapidly following ligand-induced activation. Ligand-induced internalization of DOR-0cK was never inhibited relative to wild type DOR and was in fact moderately but consistently enhanced, an observation that was confirmed in multiple independent cell clones (Fig 2B) . Analysis of the fate of endocytosed receptors by surface biotinylation (23) indicated that DOR was extensively proteolyzed within 2 hours after endocytosis (Fig 2C, top panel) , as previously reported (5). Significantly, DOR-0cK exhibited similarly rapid and pronounced proteolysis after ligand-induced endocytosis, despite the complete lack of potentially ubiquitinated lysine residues in its cytoplasmic domains (Fig. 2C, bottom panel) . Confirming these observations, ligand-induced degradation of the DOR-0cK mutant receptor was indistinguishable from that of DOR when quantified at two time points in multiple experiments (Fig. 2D) . These results suggest that ubiquitination of DOR is not required either for the initial endocytosis of receptors following ligand-induced activation or for their subsequent sorting to lysosomes.
To independently examine whether DOR is capable of trafficking to lysosomes in the absence of cytoplasmic ubiquitination, we utilized confocal fluorescence microscopy to visualize the localization of internalized DOR relative to the late endosome / lysosomal membrane marker LAMP1. DOR and DOR-0cK were localized primarily in the plasma membrane in the absence of agonist and, consistent with previous studies (5,36), were observed in early endosomes within several minutes after addition of agonist to the culture medium (not shown). Importantly, both DOR and DOR-0cK colocalized extensively with LAMP1 within 60 minutes after agonist addition (Fig 3A) . The extensive colocalization of both DOR and DOR-0cK with individual LAMP1-positive compartments was emphasized by examination of cells at higher magnification (Fig 3B) , confirming that both receptors were targeted to lysosomes under these conditions. In contrast, the mu opioid receptor examined under similar conditions was rarely observed in 
